Provided by Tiger Trade Technology Pte. Ltd.

Ginkgo Bioworks Holdings Inc.

10.10
+1.7821.39%
Post-market: 10.150.0500+0.50%19:59 EST
Volume:2.66M
Turnover:25.72M
Market Cap:611.96M
PE:-1.63
High:10.23
Open:8.93
Low:8.65
Close:8.32
52wk High:17.58
52wk Low:5.00
Shares:60.59M
Float Shares:41.54M
Volume Ratio:1.70
T/O Rate:6.40%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.2132
EPS(LYR):-10.5411
ROE:-50.02%
ROA:-15.55%
PB:1.09
PE(LYR):-0.96

Loading ...

Company Profile

Company Name:
Ginkgo Bioworks Holdings Inc.
Exchange:
NYSE
Establishment Date:
2008
Employees:
834
Office Location:
27 Drydock Avenue,8th Floor,Boston,Massachusetts,United States
Zip Code:
02210
Fax:
- -
Introduction:
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.

Directors

Name
Position
Jason Kelly
Chief Executive Officer,Founder and Director
Reshma Shetty
President,Founder and Director
Shyam Sankar
chair
Christian Henry
Director
Harry E. Sloan
Director
Kathy Hopinkah Hannan
Director
Myrtle Potter
Director
Ross Fubini
Director
Sri Kosuri
Director

Shareholders

Name
Position
Jason Kelly
Chief Executive Officer,Founder and Director
Steven Coen
Chief Financial Officer
Reshma Shetty
President,Founder and Director